Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases

被引:107
作者
Chen, Xi [1 ]
Barclay, Jeff W. [1 ]
Burgoyne, Robert D. [1 ]
Morgan, Alan [1 ]
机构
[1] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool L69 3BX, Merseyside, England
基金
英国生物技术与生命科学研究理事会;
关键词
Adult onset neuronal ceroid lipofuscinosis; Aging; Alzheimer's disease; Amyotrophic lateral sclerosis; Caenorhabditis elegans; Compound screening; Frontotemporal dementia; Huntington's disease; Neurodegeneration; Parkinson's disease; TRANSGENIC CAENORHABDITIS-ELEGANS; BETA-AMYLOID PEPTIDE; NEURONAL CEROID-LIPOFUSCINOSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; ALPHA-SYNUCLEIN AGGREGATION; SPINAL MUSCULAR-ATROPHY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LIFE-SPAN; PROTEIN AGGREGATION;
D O I
10.1186/s13065-015-0143-y
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
Age-associated neurodegenerative disorders such as Alzheimer's disease are a major public health challenge, due to the demographic increase in the proportion of older individuals in society. However, the relatively few currently approved drugs for these conditions provide only symptomatic relief. A major goal of neurodegeneration research is therefore to identify potential new therapeutic compounds that can slow or even reverse disease progression, either by impacting directly on the neurodegenerative process or by activating endogenous physiological neuroprotective mechanisms that decline with ageing. This requires model systems that can recapitulate key features of human neurodegenerative diseases that are also amenable to compound screening approaches. Mammalian models are very powerful, but are prohibitively expensive for high-throughput drug screens. Given the highly conserved neurological pathways between mammals and invertebrates, Caenorhabditis elegans has emerged as a powerful tool for neuroprotective compound screening. Here we describe how C. elegans has been used to model various human ageing-associated neurodegenerative diseases and provide an extensive list of compounds that have therapeutic activity in these worm models and so may have translational potential.
引用
收藏
页数:20
相关论文
共 139 条
[1]
Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2/insulin-like signaling pathway [J].
Abbas, S. ;
Wink, M. .
PHYTOMEDICINE, 2010, 17 (11) :902-909
[2]
Epigallocatechin Gallate from Green Tea (Camellia sinensis) Increases Lifespan and Stress Resistance in Caenorhabditis elegans [J].
Abbas, Sami ;
Wink, Michael .
PLANTA MEDICA, 2009, 75 (03) :216-221
[3]
Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan [J].
Alavez, Silvestre ;
Vantipalli, Maithili C. ;
Zucker, David J. S. ;
Klang, Ida M. ;
Lithgow, Gordon J. .
NATURE, 2011, 472 (7342) :226-229
[4]
Inflammation in neurodegenerative diseases [J].
Amor, Sandra ;
Puentes, Fabiola ;
Baker, David ;
van der Valk, Paul .
IMMUNOLOGY, 2010, 129 (02) :154-169
[5]
Reserpine ameliorates Aβ toxicity in the Alzheimer's disease model in Caenorhabditis elegans [J].
Arya, Upasna ;
Dwivedi, Hemalata ;
Subramaniam, Jamuna R. .
EXPERIMENTAL GERONTOLOGY, 2009, 44 (6-7) :462-466
[6]
Neurotoxic effects of TDP-43 overexpression in C-elegans [J].
Ash, Peter E. A. ;
Zhang, Yong-Jie ;
Roberts, Christine M. ;
Saldi, Tassa ;
Hutter, Harald ;
Buratti, Emanuele ;
Petrucelli, Leonard ;
Link, Christopher D. .
HUMAN MOLECULAR GENETICS, 2010, 19 (16) :3206-3218
[7]
Aspirin Inhibits Oxidant Stress, Reduces Age-Associated Functional Declines, and Extends Lifespan of Caenorhabditis elegans [J].
Ayyadevara, Srinivas ;
Bharill, Puneet ;
Dandapat, Abhijit ;
Hu, Changping ;
Khaidakov, Magomed ;
Mitra, Sona ;
Reis, Robert J. Shmookler ;
Mehta, Jawahar L. .
ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (05) :481-490
[8]
Neurotransmitter release mechanisms studied in Caenorhabditis elegans [J].
Barclay, Jeff W. ;
Morgan, Alan ;
Burgoyne, Robert D. .
CELL CALCIUM, 2012, 52 (3-4) :289-295
[9]
Resveratrol, sirtuins, and the promise of a DR mimetic [J].
Baur, Joseph A. .
MECHANISMS OF AGEING AND DEVELOPMENT, 2010, 131 (04) :261-269
[10]
Exome-Sequencing Confirms DNAJC5 Mutations as Cause of Adult Neuronal Ceroid-Lipofuscinosis [J].
Benitez, Bruno A. ;
Alvarado, David ;
Cai, Yefei ;
Mayo, Kevin ;
Chakraverty, Sumitra ;
Norton, Joanne ;
Morris, John C. ;
Sands, Mark S. ;
Goate, Alison ;
Cruchaga, Carlos .
PLOS ONE, 2011, 6 (11)